2-(beta-Phenethyl-hydrazono)-propionate as inhibitor of hepatic gluconeogenesis. Hydrazones as blood sugar lowering drugs?
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism*; D003864:Depression, Chemical; D005943:Gluconeogenesis / Q000187:drug effects*; D006168:Guinea Pigs; D006835:Hydrazones / Q000494:pharmacology*; D066298:In Vitro Techniques; D007773:Lactates / Q000494:pharmacology; D008099:Liver / Q000378:metabolism*; D008930:Mitochondria, Liver / Q000378:metabolism; D010084:Oxidation-Reduction; D010101:Oxygen Consumption / Q000187:drug effects; D010624:Phenelzine / Q000494:pharmacology*; D051381:Rats; D013386:Succinates / Q000378:metabolism
D001786:Blood Glucose; D006835:Hydrazones; D007773:Lactates; D013386:Succinates; D010624:Phenelzine